Alan S. Roemer

CIK 1643070 · last filed 2025-12-23

Alan S. Roemer is a corporate insider who has filed 23 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider was granted $50.0K of INAB on Dec 23, 2025. Across all open-market trades the lifetime net is +$34.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $55.0K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$55.0K

Companies

2

Total Filings

23

Lifetime Open-Market Net

$34.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INAB Director 49,514 $1.11 $55.0K $50.0K 13 2025-12-23
NexImmune, Inc. (NEXI) Delisted Director 0 $0.00 $0 -$16.0K 7 2023-11-22

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-12-23 INAB Grant (A) +36,232 $50.0K EDGAR
2025-05-12 INAB Grant (A) $0 EDGAR
2025-05-07 INAB Mixed +113,459 $20.9K EDGAR
2024-12-23 INAB Grant (A) $0 EDGAR
2024-10-08 INAB Mixed +126,582 $0 EDGAR
2024-06-14 INAB Grant (A) $0 EDGAR
2023-12-15 INAB Grant (A) +102,459 $0 EDGAR
2023-11-22 Notice (144/A) −3,992 -$7.8K EDGAR
2023-11-22 Notice (144/A) −3,833 -$8.3K EDGAR
2023-11-22 NexImmune, Inc. (NEXI) Delisted Sell (S) −7,825 -$16.0K EDGAR
Showing 110 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.